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Abstract
Background: Platelet-derived growth factor (PDGF) is a potent stimulator of growth and motility of vascular
smooth muscle cells (VSMCs). Abnormalities of PDGF/PDGF receptor (PDGFR) are thought to contribute to vascular
diseases and malignancy. We previously showed that a carotenoid, lycopene, can directly bind to PDGF and affect
its related functions in VSMCs. In this study we examined the effect of the other naturally occurring carotenoid,
lutein, on PDGF signaling and migration in VSMCs.
Methods: Western blotting was performed to examine PDGF and H2O2 signaling. Flowcytometry was used to
determine PDGF binding to VSMCs. Fluorescence microscopy was performed to examine intracellular ROS
production. Modified Boyden chamber system (Transwell apparatus) was used for migration assay.
Results: Lutein reduced PDGF signaling, including phosphorylation of PDGFR-b and its downstream protein
kinases/enzymes such as phospholipase C-g, Akt, and mitogen-activated protein kinases (MAPKs). Although lutein
possesses a similar structure to lycopene, it was striking that lutein inhibited PDGF signaling through a different
way from lycopene in VSMCs. Unlike lycopene, lutein not only interacted with (bound to) PDGF but also interfered
with cellular components. This was evidenced that preincubation of PDGF with lutein and treatment of VSMCs
with lutein followed by removing of lutein compromised PDGF-induced signaling. Lutein reduced PDGF-induced
intracellular reactive oxygen species (ROS) production and attenuated ROS- (H2O2-) induced ERK1/2 and p38 MAPK
activation. A further analysis indicated lutein could inhibit a higher concentration of H2O2-induced PDGFR signaling,
which is known to act through an oxidative inhibition of protein tyrosine phosphatase. Finally, we showed that
lutein functionally inhibited PDGF-induced VSMC migration, whereas its stereo-isomer zeaxanthin did not, revealing
a special action of lutein on VSMCs.
Conclusions: Our study reveals a differential action mechanism of lutein from other reported caroteinoids and
suggests a possible beneficial effect of lutein but not zeaxanthin on prevention of vascular diseases.
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Background
Abnormal vascular smooth muscle cell (VSMC) prolif-
eration and migration play an important role in the
development and progression of proliferative cardiovas-
cular diseases (CVDs), including hypertension, resteno-
sis, and atherosclerosis [1-3].
Platelet-derived growth factor (PDGF) is a potent sti-
mulator of growth and motility of connective tissue cells
such as fibroblasts and SMCs [4]. PDGF is a dimeric
molecule consisting of disulfide-bonded A and B-poly-
peptide chains. Homodimeric (PDGF-AA, PDGF-BB) as
well as heterodimeric (PDGF-AB) isoforms exert their
effects on target cells by binding with different specifici-
ties to two structurally related protein tyrosine kinase
receptors, denoted a- and b-receptors [4,5].
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Abnormalities of PDGF receptor (PDGFR)/PDGF are
thought to contribute to a number of human diseases,
including malignancy and vascular diseases.
PDGF participates in stimulating SMC proliferation
and migration during atherosclerosis [6]. Expression of
PDGF is low in normal blood vessels, but the levels of
PDGF mRNA are increased following vascular smooth
muscle cell transition into a synthetic state in culture
[7] or after injury in vivo [8]. PDGF and its cognate
receptors are also expressed in tumors [9]. PDGF stimu-
lates autocrine growth of tumor cells and regulate
tumor stromal fibroblasts and tumor angiogenesis [10].
Overexpression of PDGF receptor and/or ligand is
found in brain tumors and diverse malignancies.
In addition to PDGF, vascular injury also induces oxi-
dative stress and elevated production of reactive oxygen
species (ROS) in the vessel wall [11,12]. Oxidative stress
has been suggested to play an important role in the
pathogenesis of CVDs, mainly through oxidative modifi-
cation of low density lipoprotein, which initiates vascu-
lar inflammation and atherosclerotic lesion formation
[13]. The most important ROS for pathological condi-
tions are superoxide (O2-) and hydrogen peroxide
(H2O2). Inhibition of ROS reduces vessel remodeling
and restenosis [14]. Moreover, PDGFR activation
increases intracellular ROS production and mediates
PDGF signal transduction [15]. It was reported that
both PDGF and extracellular H2O2 at a higher concen-
tration stimulation lead to intracellular ROS production
and regulate protein tyrosine phosphatase (PTP), which
induces an elevation of tyrosine-phosphorylated proteins
[16-18].
Lutein and its stereo-isomer, zeaxanthin, are carote-
noids without provitamin A activity and found in a wide
variety of fruits and vegetables, including cooked spi-
nach, lettuce, broccoli, peas, lima beans, orange juice,
celery, string beans, and squash [19,20]. It has been
reported that higher quantities of dietary lutein were
associated with lower risks of total stroke in the Health
Professionals’ Follow-Up Study [21]. Moreover, two
other key studies have provided support for a role of
lutein and zeaxanthin in prevention of cardiovascular
diseases, which shows inverse correlation of plasma
lutein concentration and carotid intima-media thickness
[20]. In an in-vitro study, lutein and other carotenoids
such as lycopene have been shown to reduce adhesion
molecules expression in human aortic endothelial cells
[22]. This reflects a possible role of lutein in the preven-
tion of atherosclerosis. Lutein exists in high concentra-
tion in the macula [23]. However, dietary lutein
stimulated delayed type hypersensitivity response, the
number of CD4+ Th cells, and IgG production in dogs
[24], suggesting its presence in peripheral areas and a
possible protective role of lutein in vascular system.
We previously demonstrated that lycopene inhibits
VSMC proliferation and migration through direct inter-
action with PDGF [25,26]. The predominant carotenoids
found in human plasma are lycopene, b-carotene, and
lutein, and their concentrations vary from 0 to 8 μM
depending upon dietary intake [27]. In this study we
evaluated lutein and its stereo isomer zeaxanthin on
VSMC migration and PDGF signaling. Our results
revealed a differential action mechanism of lutein from
lycopene in inhibiting PDGF signaling and an opposite
action of lutein and zeaxanthin on VSMC migration.
Materials and methods
Materials
The inhibitors for mitogen activated protein kinases
(MAPKs) and phosphoinositide-3-kinase (PI-3K), bovine
type I collagen and (+/-)-6-hydroxy-2,5,7,8-tetramethyl-
chromane-2-carboxylic acid (Trolox) were purchased
from Sigma Chemical Co. (St Louis, MO, USA). Hydro-
gen peroxide (H2O2) was from Merck KGaA Co. (Darm-
stadt, Germany). Antibodies (Abs) raised against
phospho-ERK1/2 and PDGFR-b were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Ab raised against
phospho-PDGFR was from Upstate Biotech Inc. (Lake
Placid, NY, USA). Abs directed against PLCg1, phospho-
PLCg1 (Tyr783), total p38 MAPK, phospho-p38 MAPK
and total Akt were from Cell Signaling Technology, Inc.
(Danvers, MA, USA). Recombinant PDGF-BB and Ab
for total ERK1/2 were from R&D systems, Inc. (MN,
USA). Lutein and zeaxanthin were purchased from
Extrasynthese (Genay cedex, France) and were dissolved
in dimethyl sulfoxide (DMSO) and tetrahydrofuran,
respectively.
Cell Culture
The animal experimental procedures were approved by
the Fu-Jen Animal Experiment Committee. Rat aortic
SMCs were isolated and characterized as previously
described [25] and cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal bovine
serum (FBS), penicillin (100 units/ml), streptomycin
(100 μg/ml) and fungizone (250 ng/ml) (Invitrogen Life
Technologies, Carlsbad, CA, USA). Four to six passage
cells were used in this study. Unless otherwise indicated,
cells reaching 80-90% of confluency were starved and
synchronized in DMEM at 37°C for 24 h and then sub-
jected to further analysis.
Cell lysate preparation and Western blot analysis
Cell lysate was prepared as previously described [26].
Total proteins were separated by electrophoresis on SDS-
polyacrylamide gels, electroblotted onto PVDF mem-
branes, and then probed using a primary mAb. Immuno-
blots were detected by enhanced chemiluminescence
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reagent (Perkin-Elmer, Waltham, MA, USA). For some
experiments, membranes were stripped with a striping
buffer (62.5 mM Tris-HCl, pH 6.7, 2% SDS and 100 mM
b-mercaptoethanol), washed, and reprobed with Abs for
the levels of a-tubulin or the corresponding total pro-
teins and developed as described above.
Cell migration assay
Migration assay with VSMCs was performed using a
modified Boyden chamber model (Transwell apparatus,
8.0-μm pore size, Costar). Briefly, the lower face of poly-
carbonate filter (Transwell insert) was coated with type I
collagen (10 μg/ml) for 30 min in the laminar flow
hood. The lower chamber was filled with serum-free,
PDGF-BB-containing medium preincubated with vehicle
(DMSO) or lutein for 30 min. VSMCs (2.5 × 105 cells/
ml) were plated to the upper chamber in the presence
of vehicle or lycopene. After 3 h of incubation, all non-
migrant cells were removed from the upper face of the
Transwell membrane with a cotton swab and migrant
cells were fixed and stained with 0.5% toluidene blue in
4% paraformaldehyde. Migration was quantified by
counting the number of stained cells per × 100 field
(high power field, HPF) under the phase-contrast micro-
scope (Leica DMIL®) and photographed.
Flowcytometric analysis of PDGF-BB binding to VSMCs
Flowcytometric analysis of PDGF binding to VSMCs
was performed according to the manufacturer’s protocol
of the PDGF-BB biotinylated fluorokine kit (R&D sys-
tems, Inc., MN, USA). Briefly, cells were incubated at
37°C for 1 h to allow regeneration of the receptors.
Cells (1 × 105) were then stained with biotinylated pro-
tein (soybean trypsin inhibitor, as a negative control) or
biotinylated PDGF-BB at 4°C for 1 h in the presence of
lutein or anti-PDGF-BB blocking Ab. After incubated
with the fluorescein-conjugated avidin, cells were ana-
lyzed immediately by Partec CyFlow ML cytometer (Par-
tech GmBH, Munster, Germany) using excitation and
emission wavelength at 488 and 525 nm, respectively.
Fluorescence signals from 7,500 cells were collected to
calculate mean fluorescence intensity of a single cell.
Fluorescence microscopic analysis of intracellular ROS
level
Intracellular production of ROS was determined by the
fluorescence microscopy as previously described [28]
with minor modifications. Briefly, VSMCs were pre-
treated with lutein (10 μM) for 30 min and followed by
stimulation with vehicle- or lutein-pretreated PDGF (10
ng/ml) at 37°C for 10 min. After a brief wash, cells were
loaded with CM-H2DCFDA (5 μg/ml, Invitrogen) and
incubated at 37°C for 15 min. After washed with PBS,
cells were immediately analyzed under the fluorescence
microscope (Nikon Eclipse Ti-S, Japan) using excitation
and emission wavelength at 485 and 525 nm, respec-
tively, and photographed by a digital camera. The fluor-
escence intensity of the positive staining cells was
calculated based on their gray levels (from 0 to 255), as
judged by image analysis software of Image-Pro Plus
(Media Cybernetics, Inc., Baltimore, MD, USA).
Statistical analysis
Data were expressed as mean ± standard error mean
(SEM). Comparison of means of two groups of data was
made by using the unpaired, two-tailed Student t test.
Results
Lutein inhibits PDGF signaling in VSMCs
It has been reported that PDGF-BB binding to PDGFR
(PDGF receptor) is associated with activation of
PDGFR-tyrosine kinase activity [4], subsequently causing
VSMC proliferation and migration through activation of
downstream signaling [29]. To examine the effect of
lutein on PDGF-BB-induced signal transduction path-
way, the activation of PDGFR-b and its downstream
kinases in VSMCs was determined. It was found that
lutein inhibited PDGF-BB-induced PDGFR-b, PLCg,
Akt, and MAPKs phosphorylation in a concentration-
and time-dependent manner (Figures 1 and 2).
Lutein affects PDGF signaling through interaction with
both PDGF and cellular components
In our previous study we have demonstrated that PDGF
signaling affected lycopene is not through intracellular
inhibition but is through direct interaction with PDGF
[25,26]. Because lutein reduced PDGF signaling (Figures
1 and 2), we examined whether lutein acted similarly to
lycopene. First, the effect of lutein on PDGF was exam-
ined using the pharmacological indirect approach. Med-
ium containing PDGF-BB was preincubated with vehicle
or lutein for a certain time and was added to VSMCs.
The preincubation resulted in a time-dependent inhibi-
tion on PDGF-induced PDGFR-b, PLC-g, and Akt phos-
phorylation, while PDGF signaling was not affected in
vehicle-treated control cells. Moreover, the inhibition
was pronounced at 30- and 60-min preincubation of
PDGF with lutein (Figure 3A), suggesting that lutein
directly interacted with PDGF. To confirm lutein inter-
acting with PDGF, we performed PDGF binding assay.
As determined by flowcytometric analysis, the mean
fluorescence of VSMCs was increased by adding fluores-
cein-labeled PDGF but was decreased in the presence of
an anti-PDGF blocking Ab, suggesting a specific interac-
tion between PDGF and VSMCs. Lutein slightly inhib-
ited PDGF binding at 5 μM but markedly inhibited
PDGF binding to VSMC at 10 μM (Figure 3B). Sec-
ondly, we determined whether lutein affected cellular
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components during PDGF signaling. To ensure lutein
entering into cytosol, cells were preincubated with lutein
for a longer time (1 and 6 h) and followed by an exten-
sive wash to remove extracellular unbound lutein. Cells
with a slight orange color suggest an uptake of lutein
into intracellular space (data not shown). Under this
condition, cell viability was not significantly altered (Fig-
ure 4A). However, PDGF-BB-induced PDGFR-b and
PLC-g phosphorylation was affected in VSMCs pre-
treated with lutein (Figure 4B), indicating an inhibition
on intracellular components by lutein.
Lutein inhibits PDGF-induced ROS production and
oxidative stress-induced signaling in VSMCs
Since intracellular components were affected by lutein
during PDGF signaling. Next, we tested whether lutein
could affect PDGF-induced intracellular ROS produc-
tion. As shown in Figure 5A, an obvious increase in
intracellular ROS production was observed after VSMCs
stimulated with PDGF-BB. Lutein markedly attenuated
PDGF-induced intracellular ROS production, i.e. a
decrease in fluorescence-positive cells. Further, we
investigated the effect of lutein on H2O2-induced signal-
ing in VSMCs. As reported by others, in our experimen-
tal system 50 μM of H2O2 could activate MAPKs
signaling, including activation of ERK1/2 and p38
MAPK within 30-min stimulation. The activation by
H2O2 was inhibited by lutein, whereas total MAPKs
were not affected (Figure 5B). Since H2O2 at a higher
concentration can directly activate PDGFR-b and its
downstream signaling components in VSMCs through
redox inactivation of PTP [30], we also examined
whether lutein affected H2O2 (3 mM)-induced PDGF
signaling. It was found that H2O2-induced PDGFR and
PLC-g phosphorylation was inhibited in a concentra-
tion-dependent manner.
MAPKs, PI-3K, and ROS are involved in PDGF-BB-induced
VSMC migration
It has been reported that PDGF causes cell proliferation
and migration through activation of ERK1/2 and other
signaling enzymes [4,29]. Moreover, antioxidants have
been shown to inhibit PDGF-induced VSMC migration
Figure 1 Dose-dependent effect of lutein on PDGF-induced
cellular signaling. PDGF-BB was preincubated with vehicle or the
indicated concentrations of lutein for 30 min and was added to
VSMCs for 10 min. Cells were harvested and lysates were analyzed
by Western blotting (n = 4).
Figure 2 Time-dependent effect of lutein on PDGF-induced
cellular signaling. PDGF-BB was preincubated with vehicle or
lutein for 30 min and was added to VSMCs for the indicated time
periods. After incubation, cells were harvested and lysates were
analyzed by Western blotting (n = 3).
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[17]. However, the PDGFR downstream signaling com-
ponents responsible for VSMC migration have not been
demonstrated in our system. Therefore, we examined
the role of MAPKs, PI-3K, and ROS in VSMC migra-
tion. The following inhibitors were used in the migra-
tion assay, including PD98059 (an inhibitor targeting
ERK signaling), SB202190 (a p38 MAPK inhibitor),
LY294002 (a PI-3K inhibitor), N-acetylcysteine (NAC)
and Trolox (a vitamin E derivative). Figure 6 showed
that some VSMC migration toward collagen in a basal
condition. By PDGF-BB stimulation, VSMC migration
was apparently increased about 2 folds. It was found
that PDGF-BB-induced VSMC migration was attenuated
by PD98059, SB202190 and LY294002 but was markedly
inhibited by the ROS inhibitors (Figure 6). The inhibi-
tory profile was different from those on PDGF-AA-
induced migration in VSMCs [26], excluding the possi-
bility of cytotoxicity exhibited by these inhibitors. Taken
together, the result revealed that activation of ERK, p38
MAPK, PI-3K and ROS was essential for PDGF-BB-
induced migration.
Lutein but not zeaxanthin inhibits PDGF-BB-induced
VSMC migration
Lutein elicited an inhibitory effect on PDGF-BB-induced
signal transduction pathway such as PDGFR, PLCg,
MAPKs, and ROS production. Next, we examined
whether lutein functionally affected PDGF-BB-induced
VSMC migration. As shown in Figure 7A, lutein did not
inhibit basal migration, but it inhibited PDGF-BB-
induced migration in a concentration-dependent manner
in VSMCs. Interestingly, zeaxanthin, a stereo-isomer of
lutein, did not significantly inhibit PDGF-BB-induced
migration even at 10 μM (Figure 7B). However, a
further analysis showed that zeaxanthin could inhibit
PDGF-BB-induced PDGFR and PLCg activation, but it
only slightly affected Akt, ERK1/2, and p38 MAPK acti-
vation (Figure 8).
Figure 3 Lutein interferes with PDGF binding to VSMCs. (A) PDGF was preincubated with vehicle (control) or lutein for the indicated time
and was added to stimulate cells for 10 min. Cells were then harvested and lysates were analyzed by Western blotting (n = 3). (B)
Flowcytometric analysis of PDGF binding to VSMCs. Fluorescein-labeled soybean trypsin inhibitor (basal) or PDGF were added to VSMCs in the
presence of DMSO (control), lutein (5 and 10 μM), or anti-PDGF blocking Ab at 4°C for 1 h, cells were analyzed by flowcytometry. The
representative histograms and quantitative data were shown (n = 3-4).
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Discussion
PDGF has been demonstrated as a critical growth factor
in participating in the development of vascular diseases
and tumor. Several natural compounds, such as (-)-epi-
gallocatechin-3-gallate (a tea polyphenol) [31,32], luteo-
lin (a flavonoid) [33] and chrysin [18], have been
demonstrated to affect PDGF-induced signaling, migra-
tion, or proliferation. In our previous study lycopene
was able to inhibit PDGF-AA, -AB and -BB-induced sig-
naling and reduce balloon-induced neointima formation
in rat carotid artery injury [25,26]. In this study, we pre-
sented findings to demonstrate that the carotenoid
lutein inhibited PDGF-induced signaling and function-
ally blocked migration in VSMCs (Figures 1, 2, and 7).
Moreover, lutein inhibited oxidative stress (H2O2)-
induced signaling and a higher concentration of H2O2-
induced signaling (Figure 5). In striking contrast, the
isomer zeaxanthin did not affect VSMC migration even
at an equal concentration with lutein (Figure 7). There-
fore, our results suggest that these carotenoids act in a
differential way in affecting PDGF signaling and func-
tions in VSMCs.
Regarding how lutein affected cellular signaling in
VSMCs, it was found that lutein reduced PDGF signaling
in a time- and concentration-dependent manner (Figures
1 and 2). The effect was profound when PDGF was prein-
cubated with lutein (Figure 3A), suggesting lutein inter-
acted with PDGF and interfered with PDGF binding to
its cognate receptors. This was confirmed by the flowcy-
tometric analysis that fluorescein-labeled PDGF binding
to VSMCs was significantly reduced by lutein at 10 μM
(Figure 3B). However, unlike lycopene, lutein attenuated
VSMCs signaling through affecting cellular components.
When cells were preincubated with lutein and followed
by an extensive wash to remove extracellular lutein that
may interact with PDGF, PDGF signaling was also signifi-
cantly reduced (Figure 4B). This was not due to cytotoxi-
city by lutein because this interference did not cause any
decreases in cell viability (Figure 4A). It has been
reported that PDGFR activation enhances intracellular
reactive oxygen species (ROS) production and mediates
PDGF signal transduction [15]. PDGF and extracellular
H2O2 stimulation lead to intracellular ROS production
and regulate protein tyrosine phosphatase (PTP), which
induces an elevation of tyrosine-phosphorylated proteins
[16]. In this study we observed an elevation of intracellu-
lar ROS production after PDGF stimulation by fluores-
cence microscopy. This increase was abrogated by lutein
(Figure 5A), suggesting that lutein might act as a ROS
scavenger or an inhibitor affecting upstream of ROS. A
further analysis confirmed lutein acting as a ROS scaven-
ger because it inhibited H2O2 (50 μM)-induced ERK1/2
and p38 MAPK activation in VSMCs (Figure 5B), which
was activated independent of PDGFR activation. This
could be also demonstrated by the observation that lutein
inhibited PDGFR signaling induced by a higher concen-
tration of H2O2 (3 mM) (Figure 5C), which is known to
directly activate PDGFR-b and its downstream signaling
components in VSMCs through an intracellular ROS
increase and redox inactivation of PTP [30]. Since PTP is
responsible for dephosphorylating phosphorylated tyro-
sine residues in activated tyrosine kinases, this suggests a
direct effect of lutein on ROS content or activated tyro-
sine kinases.
It is an interesting issue that the carotenoids with a
similar structure act in a differential way on VSMCs.
Figure 4 Lutein affects cellular components . (A) Cells were
incubated with vehicle or lutein (10 μM) for 16 h and cell viability
was measured by MTT assay as described in Methods. (B) Cells were
preincubated with vehicle or lutein (10 μM) for 1 or 6 h and
followed by an extensive wash to remove extracellular unbound
lutein. Cells were then stimulated with PBS or PDGF for 10 min.
PDGFR and PLCg phosphorylation was examined by Western
blotting and quantitation was performed by densitometry (n = 3).
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Our previous studies have shown that lycopene affects
PDGF signaling through interaction with PDGF but not
cellular components [25,26]. However, in this study we
found that lutein affected PDGF binding, cellular com-
ponents, and then migration, whereas zeaxanthin did
not inhibit PDGF-induced migration (Figure 7B). The
ineffectiveness of zeaxanthin on PDGF-induced migra-
tion is very intriguing. There is a report that zeaxanthin
can inhibit PDGF-BB-induced migration in human der-
mal fibroblasts. The authors concluded that zeaxanthin
affects cellular components but does not directly inter-
act with PDGF-BB [34]. In our system, zeaxanthin was
found to inhibit PDGF-BB-induced PDGFR and PLCg
activation; however surprisingly it only marginally
affected Akt, ERK1/2, and p38 MAPK activation (Figure
8). Since ERK, p38 MAPK, PI-3K and ROS were
required for PDGF-BB-induced VSMC migration (Figure
6), the less effectiveness of zeaxanthin on these kinases
activation (Figure 8) may partly explain this phenom-
enon. Lycopene, lutein, and zeaxanthin are all isopre-
noids with polyene skeleton (chain). Only lycopene is
linear (acyclic) and the skeleton of the other two are
modified by cyclization at both ends to give different
end groups [35]. It has been reported that carotenoids
Figure 5 Effect of lutein on PDGF-induced intracellular ROS production and H2O2 signaling. (A) VSMCs were treated with PDGF-BB (PDGF,
10 ng/ml) in the presence of vehicle (veh) or lutein (10 μM) for 10 min. Cells were immediately analyzed by fluorescence microscopy. The
representative data from an experiment were shown (n = 5). The mean fluorescence intensity from the positive staining cells was calculated by the
image analysis software. *P < 0.05 vs. control. (B and C) VSMCs were pretreated with vehicle (veh) or lutein for 30 min and followed by the addition of
(B) H2O2 (50 μM) or (C) H2O2 (3 mM) for the indicated time. Cellular signaling was determined by Western blotting (n = 3). Quantitation of MAPKs and
PDGFR and PLCg phosphorylation was performed by densitometry. Data were expressed as (B) a bar graph or (C) indicated by a number.
Figure 6 Effect of kinase and ROS inhibitors on PDGF-BB-
induced VSMC migration. VSMCs were preincubated with DMSO,
kinase inhibitors (10 μM; PD for PD98059, SB for SB202190, and LY
for LY294002) or ROS inhibitors (NAC, 10 mM; trolox, 200 μM) for 30
min. Cells were added in the upper chamber and assembled with
the lower chamber containing media in the presence of PBS (basal)
or PDGF-BB (10 ng/ml). After incubation for 3 h, cells migrated to
the underside of filter membrane were photographed as described
in Methods. Cell migration was expressed as percentage of basal.
**P < 0.01 vs. control, ***P < 0.001 vs. control.
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are associated with their radical scavenging properties
and their exceptional singlet oxygen quenching abilities
[36]. However, some recent experiments by the authors
using cells in culture have shown not only loss of anti-
oxidant effectiveness but also pro-oxidant effects of
carotenoids at high carotenoid concentrations [37-40].
This suggests a diverse effect of these carotenoids.
Therefore, more efforts are needed to clarify whether
the structural differences between these caroteinoids
contribute to their differential cellular effects.
Figure 7 Lutein but not zeaxanthin inhibits VSMC migration. VSMCs were seeded in the upper chamber precoated with collagen. The
inserts were assembled with the lower chamber, which was filled with serum-free (basal) or PDGF-containing medium preincubated with vehicle
or (A) lutein or (B) zeaxanthin (zea) for 30 min. After incubation for 3 h at 37°C, fixation was performed and nonmigrated cells were removed.
Cells migrated to the underside of filter membrane were photographed and counted in high-power field (magnification, 100 ×) under the
microscope. Right panels: a quantitative analysis of migrated cells. All experiments were conducted in duplicate. Cell migration was expressed as
percentage of basal or control (n = 6-8). ***P < 0.001 versus control. NS: non significance.
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Conclusions
In this study we provided evidence that lutein interacts
with PDGF and affects cellular components, leading to
interference with PDGF intracellular signaling, and func-
tionally inhibits VSMC migration. We also demon-
strated that zeaxanthin, the stereo-isomer of lutein,
shows a distinct effect on PDGF signaling and VSMC
migration. Our findings, together with our previous
study, not only suggest the possible beneficial effect of
lutein in preventing cardiovascular diseases but also an
intriguing phenomenon of these carotenoids in inhibit-
ing of PDGF signaling, highlighting their differences in
mechanism of action in affecting VSMC behaviors.
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